Tango Therapeutics

Tango Therapeutics is a biotechnology company focused on developing novel cancer medicines using the principle of synthetic lethality. Their approach starts and ends with patients, aiming to expand the reach of genetically targeted therapies. Tango leverages a state-of-the-art CRISPR-based functional genomics target discovery platform to identify novel vulnerabilities in cancer cells with specific tumor suppressor gene loss or inactivation. This leads to the development of drugs that target these vulnerabilities, selectively killing cancer cells while sparing normal cells.

Tango has a robust pipeline of drug candidates targeting various cancer types, including those with MTAP deletions and STK11 mutations. They have ongoing clinical trials for their lead programs, TNG908, TNG462, and TNG260. The company has a strong commitment to patient health and well-being, focusing on areas with high unmet need. Tango's innovative approach and dedication to scientific excellence position them as a leader in the fight against cancer.

Tango Therapeutics is a biotechnology company focused on developing precision medicines that target specific tumors, particularly those driven by inactivated tumor suppressor genes. Their mission is to leverage the principle of synthetic lethality to create a new generation of cancer therapies that are effective and safe for patients with limited treatment options. They are driven by a deep commitment to patient health and strive to build a road map to cures that transform the lives of cancer patients and their families.

Tango Therapeutics fosters a collaborative and passionate culture that prioritizes innovation and patient impact. The company emphasizes a spirit of urgency and compassion, encouraging employees to work together to push boundaries with bold ideas. They strive to create a welcoming and inclusive environment where everyone feels valued and their contributions are recognized. This is reflected in their focus on team building and celebrating successes, while also fostering a sense of purpose in the mission to develop life-changing cancer treatments.

Tango Therapeutics prioritizes an inclusive culture, actively seeking diverse perspectives and fostering a collaborative environment where all voices are heard and valued. Their commitment to equity is evident in their efforts to provide opportunities for growth and development regardless of background, ensuring everyone feels respected, empowered, and supported. This dedication to DEI is reflected in their diverse workforce and their belief in the power of a team united by shared goals and a passion for innovation.